These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22527647)

  • 41. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
    Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bilateral forearm intravenous regional anesthesia with prilocaine for botulinum toxin treatment of palmar hyperhidrosis.
    Bosdotter Enroth S; Rystedt A; Covaciu L; Hymnelius K; Rystedt E; Nyberg R; Naver H; Swartling C
    J Am Acad Dermatol; 2010 Sep; 63(3):466-74. PubMed ID: 20708471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin for treatment of craniofacial hyperhidrosis.
    Böger A; Herath H; Rompel R; Ferbert A
    J Neurol; 2000 Nov; 247(11):857-61. PubMed ID: 11151418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duration of Efficacy Increases with the Repetition of Botulinum Toxin A Injections in Primary Axillary Hyperhidrosis: A 15-year Study in 117 Patients.
    Berthin C; Maillard H
    Acta Derm Venereol; 2019 Dec; 99(13):1237-1240. PubMed ID: 31453629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iodine-Starch test for assessment of hyperhidrosis in amputees, evaluation of different methods of application.
    Hansen C; Wayment B; Klein S; Godfrey B
    Disabil Rehabil; 2018 Dec; 40(25):3076-3080. PubMed ID: 28826272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study.
    Grimstad Ø; Kvammen BØ; Swartling C
    Am J Clin Dermatol; 2020 Oct; 21(5):741-748. PubMed ID: 32761500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decrease in phantom limb pain associated with prosthesis-induced increased use of an amputation stump in humans.
    Weiss T; Miltner WH; Adler T; Brückner L; Taub E
    Neurosci Lett; 1999 Sep; 272(2):131-4. PubMed ID: 10507559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperhidrosis of the residual limb: a narrative review of the measurement and treatment of excess perspiration affecting individuals with amputation.
    Lannan FM; Powell J; Kim GM; Hansen CR; Pasquina PF; Smith DG
    Prosthet Orthot Int; 2021 Dec; 45(6):477-486. PubMed ID: 34723907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
    Glaser DA
    Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Painful and nonpainful phantom and stump sensations in acute traumatic amputees.
    Schley MT; Wilms P; Toepfner S; Schaller HP; Schmelz M; Konrad CJ; Birbaumer N
    J Trauma; 2008 Oct; 65(4):858-64. PubMed ID: 18849803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
    Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
    Swartling C; Naver H; Lindberg M
    Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of plantar hyperhidrosis with botulinum toxin type A.
    Vadoud-Seyedi J
    Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
    Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
    Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of phantom limb pain with botulinum toxin type A.
    Jin L; Kollewe K; Krampfl K; Dengler R; Mohammadi B
    Pain Med; 2009 Mar; 10(2):300-3. PubMed ID: 19207237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin A for palmar hyperhidrosis.
    Wollina U; Karamfilov T
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):555-8. PubMed ID: 11843216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.